Fate Therapeutics (FATE) Net Margin (QoQ) (2012 - 2026)
Powered by 
Analysis
Fate Therapeutics (FATE) Net Margin (QoQ) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Fate Therapeutics | 299.79 Mn | 299.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 97,599.00 |
| Mar 31, 2026 | -2,262.00 |
| Dec 31, 2025 | -52,685.00 |
| Sep 30, 2025 | -6,184.00 |
| Jun 30, 2025 | 54,391.00 |
| Mar 31, 2025 | 78,222.00 |
| Dec 31, 2024 | -155,201.00 |
| Sep 30, 2024 | -96,505.00 |
| Jun 30, 2024 | 184,290.00 |
| Mar 31, 2024 | 16,772.00 |
| Dec 31, 2023 | -20,888.00 |
| Sep 30, 2023 | 384,003.00 |
| Jun 30, 2023 | -619,401.00 |
| Mar 31, 2023 | 9,652.00 |
| Dec 31, 2022 | 42,600.00 |
| Sep 30, 2022 | -12,077.00 |
| Jun 30, 2022 | -4,184.00 |
| Mar 31, 2022 | 261.00 |
| Dec 31, 2021 | -2,278.00 |
| Sep 30, 2021 | -3,576.00 |